|
06 Feb 2007 |
Arena Pharmaceuticals Completes Enrollment with 3,182 Patients in Lorcaserin Phase 3 BLOOM Trial for Obesity
|
|
06 Feb 2007 |
elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia
|
|
06 Feb 2007 |
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Hepatitis
|
|
06 Feb 2007 |
Cyclacel announces development plan for its seliciclib CDK inhibitor to treat nasopharyngeal cancer
|
|
05 Feb 2007 |
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women
|
|
03 Feb 2007 |
GlaxoSmithKline receives approvable letter for new indications for Arixtra(R) (fondaparinux sodium) injection
|
|
03 Feb 2007 |
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
|
|
03 Feb 2007 |
Biodelivery Sciences Announces FDA Acceptance of Bioral Amphotericin IND
|
|
03 Feb 2007 |
Hollis-Eden Pharmaceuticals Presents Positive Data with HE3286 in Preclinical Model of Established Rheumatoid Arthritis
|
|
03 Feb 2007 |
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
|
|
03 Feb 2007 |
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
|
|
03 Feb 2007 |
Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea(TM) (doxycycline, USP) Capsules, 40 mg, in Combination with MetroGel® (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of the AAD
|
|
02 Feb 2007 |
Metabasis Announces Completion of Enrollment in the Phase 2b Clinical Trial for CS-917 in Patients With Type 2 Diabetes
|
|
02 Feb 2007 |
Neurochem announcement regarding the completion of its North American Phase III clinical trial for tramiprosate (ALZHEMEDâ„¢) for the treatment of Alzheimer's disease
|
|
02 Feb 2007 |
Preliminary clinical data for mecamylamine (AGI-004) and arbaclofen (AGI-006)
|
|
01 Feb 2007 |
AstraZeneca and Palatin Technologies Announce Worldwide Collaboration to Discover, Develop and Commercialise Obesity Compounds
|
|
01 Feb 2007 |
Lab International Initiates Patient Enrollment In The Extension Of Its Phase IIB Fentanyl Taifun(R) Trial
|
|
01 Feb 2007 |
Curis, Inc. Announces Dosing of First Patient in Hedgehog Antagonist Phase I Clinical Trial
|
|
01 Feb 2007 |
Pharmion Announces FDA Acceptance of IND for Oral Azacitidine
|
|
01 Feb 2007 |
Theratechnologies launches confirmatory Phase 3 trial testing TH9507
|
|
01 Feb 2007 |
NeuroDerm's Transdermal L-DOPA Parkinson’s Patch Completes First Clinical Trial
|
|
01 Feb 2007 |
Polydex Pharmaceuticals Drug Trial Halted After HIV Risk Seen
|
|
01 Feb 2007 |
Athenagen’s Eye Drop Therapy for AMD is Safe and Well Tolerated in Phase I Study
|
|
01 Feb 2007 |
Gemin X Initiates Phase 1/2 Combination Trials with GX15-070 in Non-Small Cell Lung Cancer and Mantle Cell Lymphoma
|
|
01 Feb 2007 |
Nexmed Announces Patient Dosing In Phase 3 Program For Anti-Fungal Product
|
